Targeting GIRK Channels for the Development of New Therapeutic Agents. - Wikidata - awgldk - TriplyDB

Targeting GIRK Channels for the Development of New Therapeutic Agents.

Targeting GIRK Channels for the Development of New Therapeutic Agents.

http://www.wikidata.org/entity/Q34068551

about

Research Resource: Real-Time Analysis of Somatostatin and Dopamine Receptor Signaling in Pituitary Cells Using a Fluorescence-Based Membrane Potential Assay.Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells Pharmacological Characterization of 5-HT1A Autoreceptor-Coupled GIRK Channels in Rat Dorsal Raphe 5-HT Neurons.Ion channel screening: advances in technologies and analysis.G-protein-gated Inwardly Rectifying Potassium Channels Modulate Respiratory Depression by Opioids Associations between KCNJ6 (GIRK2) gene polymorphisms and pain-related phenotypes.Optical control of neuronal activity using a light-operated GIRK channel opener (LOGO).Finding inward rectifier channel inhibitors: why and how?Inward rectifier potassium (Kir) current in dopaminergic periglomerular neurons of the mouse olfactory bulb.Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.A continuous, fluorescence-based assay of μ-opioid receptor activation in AtT-20 cells.Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators.Optical control of GIRK channels using visible light.

P2860

Q33631389-03435C88-318E-4847-8846-EA07323DD2BB Q34509572-506F3AE5-9BA8-4698-9C0C-3A0D795359D6 Q35804522-FAC789B2-4BDD-4B1A-8B5E-36E156F29186 Q35937895-C4F8D2BC-9B17-4CA9-8DB9-CCCFC70DC4B0 Q36586207-1D09508C-6269-43B8-B593-9F3394FB5316 Q37353507-0AC966EA-C7E2-43E2-9284-B81E4173ABC8 Q37585109-5BE58EC6-341E-4B51-9738-CEE8CB7F401D Q40239154-9542B6D0-778A-4E7F-B17F-9C9A07256E16 Q42107643-00D9A978-30AA-413B-90BA-9268FCD282C3 Q42289796-C596F921-A852-40E4-8BC3-EEB239A56FC2 Q44336146-2A1EF642-3AD2-470A-B9B2-08E4E59CD368 Q48143981-2764B946-DD88-4AA0-B9B2-AD29024F2DCE Q50213869-99E0D57F-2CD5-4C2E-9859-316CD40FE30D

P2860

Targeting GIRK Channels for the Development of New Therapeutic Agents.

http://www.wikidata.org/entity/Q34068551

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@ast

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@en

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@nl

type

label

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@ast

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@en

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@nl

prefLabel

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@ast

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@en

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@nl

P1433

Q34068551-2879BB01-FC0A-4B12-8388-B107670BF6C2

P1476

Q34068551-AC8BB8E7-A539-480D-8236-B8AF88EB1D39

P2093

Q34068551-C067ECE4-2C95-4342-BBE6-C3DA9D6BE257

P2860

Q34068551-051F35CF-65E8-4857-9AE0-5A049B2AA642

Q34068551-0F71B27B-3A8B-4985-BAA1-06ED09DF0D44

Q34068551-197D2D55-80AD-4AD8-9496-70F1C701ED61

Q34068551-1E904905-8B2D-4027-8972-C07801C9AAA3

Q34068551-21B6EEC0-F832-48AC-B8CA-9F95DA7AB472

Q34068551-2BBE1A7B-DEEF-4CE7-BBF2-0EA097D1B384

Q34068551-2E02C186-77F1-4F98-B216-58BA88E98C36

Q34068551-33351786-7265-42B4-854B-0742B9AC9017

Q34068551-433CE2F5-958D-492D-9628-F956381893FA

Q34068551-440C621C-0BA6-4681-A947-20B076D63255

P304

Q34068551-C21CD595-1802-4B01-9104-45FB486499B8

P31

Q34068551-AE81F23A-823B-4960-8E68-5B9962DBC349

P356

Q34068551-58F5E31F-6490-4CC7-B43A-165064333297

P478

Q34068551-22FDF712-76A8-4536-98CA-DF3EBB71917E

P577

Q34068551-65B4324D-7CFD-49DC-8989-2E589ACB9D24

P5875

Q34068551-38C1CAF3-03BE-465E-869C-827D65EABA75

P698

Q34068551-73F5189C-CE71-4701-B495-1C2C46DF8923

P932

Q34068551-BA519315-796C-4432-A2EC-DD897E11209E

P356

FPHAR.2011.00064

P1433

Frontiers in Pharmacology

P1476

Targeting GIRK Channels for the Development of New Therapeutic Agents.

@en

P2093

Kenneth B Walsh

http://www.w3.org/2001/XMLSchema#string

P2860

Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches

Inwardly rectifying potassium channels: their structure, function, and physiological roles

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

A real-time screening assay for GIRK1/4 channel blockers.

HL-1 cells express an inwardly rectifying K+ current activated via muscarinic receptors comparable to that in mouse atrial myocytes.

High-throughput screening strategies for cardiac ion channels.

Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences.

A pervasive mechanism for analgesia: activation of GIRK2 channels.

The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation.

Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.

P304

64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2011.00064

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51775467

http://www.w3.org/2001/XMLSchema#string

P698

22059075

http://www.w3.org/2001/XMLSchema#string

P932

3204421

http://www.w3.org/2001/XMLSchema#string